AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

πŸ‡ΏπŸ‡Ό

AZITHROMYCIN DIHYDRATE in Zimbabwe

7 products registered with MCAZ β€” 7 active

Brand / ProductReg. No.HolderStatusExpires
CP-AZITHROMYCIN
POWDER, FOR SUSPENSION; ORAL
2025/7.2.5/6987COSPHARM PHARMACEUTICALSactive18 Jun 2030
EPIZITHRO
CAPSULE
2024/7.2.5/6656EGYPTIAN INTERNATIONAL PHARMACEUTICAL INDUSTRIES CO. (EIPICO)active5 Jul 2029
AZITHROMYCIN DIHYDRATE
TABLET, COATED; ORAL
2024/7.2.5/6557PHARMACEUTICAL AND CHEMICAL DISTRIBUTORS PRIVATE LTDactive31 Dec 2027
AZININE
TABLET, COATED; ORAL
2024/7.2.5/6549PHARMACURE DISTRIBUTORS (PVT) LTDactive31 Dec 2027
ZEE SUSPENSION
GRANULES, FOR SUSPENSION; ORAL
2022/7.2.5/6346INNOVATA PHARMACEUTICALSactive31 Dec 2027
ZEE 500
TABLET, COATED; ORAL
2018/7.2.5/5592INNOVATA PHARMACEUTICALSactive31 Dec 2027
ZEE 250
TABLET, COATED; ORAL
2018/7.2.5/5593INNOVATA PHARMACEUTICALSactive31 Dec 2027

AZITHROMYCIN DIHYDRATE β€” MCAZ Registration Details

MCAZ (Zimbabwe) has 7 registered products containing AZITHROMYCIN DIHYDRATE, of which 7 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.

Track AZITHROMYCIN DIHYDRATE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.

Azithromycin Dihydrate β€” Zimbabwe (MCAZ) | AfricaRegulatory